ライフサイエンスコーパス: vulvovaginal candidiasis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 o colonization and immunopathogenesis during vulvovaginal candidiasis.

2 protection in oral infection but exacerbate vulvovaginal candidiasis.

3 ed to fluid from healthy women or women with vulvovaginal candidiasis.

4 March 2001 from 429 patients with suspected vulvovaginal candidiasis.

5 reduce the rate of recurrence of symptomatic vulvovaginal candidiasis.

6 zole was effective in preventing symptomatic vulvovaginal candidiasis.

7 be effective for the management of recurrent vulvovaginal candidiasis.

8 anslocation, nor do we implicate the gene in vulvovaginal candidiasis among mice in pseudoestrus.

9 oth clinical studies of women with recurrent vulvovaginal candidiasis and a murine model of experimen

10 24 premenopausal women with acute recurrent vulvovaginal candidiasis and from 21 healthy asymptomati

11 infection, Trichomonas vaginalis infection, vulvovaginal candidiasis, and bacterial vaginosis) in HI

12 Vulvovaginal candidiasis, caused primarily by Candida al

13 In contrast, vulvovaginal candidiasis has a much weaker association w

14 ), gonorrhea (HR, 1.6; 95% CI, 1.1-2.2), and vulvovaginal candidiasis (HR, 1.5; 95% CI, 1.3-1.8).

15 The risks of GUD and vulvovaginal candidiasis increased with progressive leve

16 chlamydia, bacterial vaginosis, trichomonas, vulvovaginal candidiasis, pelvic inflammatory disease, g

17 Studies from women with recurrent vulvovaginal candidiasis (RVVC) and from an animal model

18 not associated with development of recurrent vulvovaginal candidiasis (RVVC) in women.

19 e and susceptibility to recurrent idiopathic vulvovaginal candidiasis (RVVC) was investigated.

20 e antifungal susceptibility of yeast causing vulvovaginal candidiasis, since cultures are rarely perf

21 women with non-antibiotic-induced recurrent vulvovaginal candidiasis suffering from acute Candida va

22 ypeptides in both bacterial vaginosis and in vulvovaginal candidiasis, suggesting that the abnormalit

23 Unlike in vulvovaginal candidiasis, the neutrophil attractant chem

24 e randomly assigned 387 women with recurrent vulvovaginal candidiasis to receive treatment with fluco

25 Vulvovaginal candidiasis (VVC) caused by Candida albican

26 Vulvovaginal candidiasis (VVC) caused by Candida albican

27 Vulvovaginal candidiasis (VVC) caused by the commensal o

28 sseminated candidiasis (HDC) and episodes of vulvovaginal candidiasis (VVC) in humans, we found evide

29 Vulvovaginal candidiasis (VVC) is a common mucosal infec

30 Vulvovaginal candidiasis (VVC) is a high-incidence disea

31 Vulvovaginal candidiasis (VVC) is an insidious infection

32 Vulvovaginal candidiasis (VVC) is an opportunistic mucos

33 Candida test using a reference standard for vulvovaginal candidiasis (VVC) of yeast culture plus exc

34 Acute and recurrent vulvovaginal candidiasis (VVC) remains a significant pro

35 s the causative agent of acute and recurrent vulvovaginal candidiasis (VVC), a common mucosal infecti

36 rial vaginosis (BV), 25 acquired symptomatic vulvovaginal candidiasis (VVC), and 7 acquired vaginal t

37 ion with lactobacilli may reduce the risk of vulvovaginal candidiasis (VVC), but supporting data are

38 Vulvovaginal candidiasis (VVC), caused by Candida albica

39 Vulvovaginal candidiasis (VVC), caused by Candida specie

40 opharyngeal candidiasis (OPC), as opposed to vulvovaginal candidiasis (VVC), is a common opportunisti

41 ections, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or Trichomonas vaginalis

42 ctions, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), particularly in the sett

43 = 2) with OPC in 1 patient, whereas isolated vulvovaginal candidiasis (VVC; n = 3) was not.

44 b-), the relative risk of chronic recurring vulvovaginal candidiasis was 2.41-4.39, depending on the

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。